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Abstract
Background:  Mediastinal  tumours  in  children  are  rare.  Around  25%  of  them  can  be  malignant.
Thymoma is  an  uncommon  neoplasm,  and  during  adulthood  it  corresponds  to  30%  of  anterior
mediastinum  tumours.  The  peak  incidence  is  between  55  and  65  years.
Clinical  case:  A  case  of  lymphocytic  thymoma  case  is  reported  in  a  4-year-old  patient  with  no
previous or  associated  symptomatology.  There  was  only  a  volume  increase  on  the  anterior  neck
region. The  neck  radiography  and  neck  and  chest  tomography  conﬁrmed  an  anterior  mediastinal
mass surrounding  the  aorta  and  vena  cava,  as  well  as  multiple  mediastinal  lymph  nodes.
Conclusions:  Early  diagnosis  and  complete  resection  are  the  basis  for  management  and  prog-
nosis.
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Timoma  en  edad  pediátrica.  Reporte  de  un  caso  y  revisión  de  la  bibliografía
Resumen
Antecedentes:  Los  tumores  de  mediastino  en  nin˜os  son  poco  frecuentes,  el  25%  de  ellos  corre-
sponde a  tumores  malignos.  El  timoma  es  una  neoplasia  poco  común,  en  adultos  corresponde  al
30% de  los  tumores  de  mediastino  anterior  y  con  un  pico  de  incidencia  es  entre  los  55-65  an˜os.
Caso clínico:  Se  reporta  el  caso  de  un  timoma  linfocítico  en  una  paciente  de  4  an˜os,  sin  sin-
tomatología  previa  ni  asociada,  solo  aumento  de  volumen  en  región  anterior  de  cuello.  Las
radiografías  y  tomografías  de  cuello  y  tórax  conﬁrman  una  masa  mediastinal  anterior,  que  rodea
a la  aorta  y  la  cava,  así  como  múltiples  adenomegalias  mediastinales.
Conclusiones:  El  diagnóstico  temprano  y  la  resección  completa  son  la  base  del  tratamiento  y
del pronóstico.
©  2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Mediastinal  tumours  in  children  are  rare.  They  represent  3%
of  total  surgical  chest  interventions  in  children.  45--50%  cor-
respond  to  primary  tumours;  of  these  40--45%  are  malignant
tumours  and  a  third  of  them  present  in  children  under  2 years
of  age.1--3 The  main  types  of  primary  tumours  are:  thymic,
neurogenic,  lymphatic,  or  of  germinal  or  mesenchymal  cells;
secondary  tumours  are  due  to  lymphatic  dissemination  of
intrathoracic  organs  towards  the  mediastinum.2 The  main
location  is  the  posterior  mediastinum  and  the  majority  are
of  neurogenic  and  benign  origin.1
Since  the  majority  of  these  tumours  are  asymptomatic,
most  are  diagnosed  as  radiographic  ﬁndings1 and  on  occa-
sion  present  as  fever,  weight  loss,  general  malaise,  severe
respiratory  failure  with  dyspnoea,  intercostal  retractions,
atelectasis  or  more  aggressively  as  superior  vena  cava
syndrome,  dysphagia,  dysphonia,  laryngeal  spasm  caused
by  recurrent  laryngeal  nerve  compromise,  diaphragmatic
paralysis  caused  by  phrenic  nerve  involvement  or  Horner
syndrome  caused  by  lymph  node  and  sympathetic  nerve
compromise.1,2 Once  the  tumour  has  been  located,  clini-
cal  study  protocol  includes:  blood  biometry,  comprehensive
metabolic  panel,  skin  and  soft  tissue  infection  panel,
and  tumour  markers.  A  lateral  projection  chest  X-ray
is  required.  The  gold  standard  is  simple  and  contrast
CAT.  On  occasions  magnetic  resonance  imaging,  iodine-
123  nuclear  medicine  imaging,  iodine-131  testing  for
ectopic  thyroid  tissues,  technetium-99  testing  to  exam-
ine  for  gastric  mucosa  in  intestinal  duplications  or  the
use  of  metaiodobenzylguanidine  for  diagnosing  neuroblas-
toma  are  carried  out.  In  children  the  use  of  cervical  and
chest  ultrasound  is  usually  useful,  or  even  ﬁne  needle
biopsy.  The  latter  may,  however,  be  limiting  for  diagno-
sis  and  there  may  be  a  risk  of  bleeding.2,4,5 Standard
treatment  consists  of  surgery  unless  tumours  are  germi-
nal  or  lymphatic.  A  cervical  and  sternal  approach  is  used,
with  the  performance  of  mediastinoscopy  or  video-assisted
thoracoscopy.4,5
The  thymus  is  a  central  lymphoid  organ,  correspond-
ing  to  the  anterior  mediastinum,  where  the  stem  cells  of
a
s
p
che  bony  medulla  are  divided  into  mature  T  lymphocytes,
ith  a  tendency  to  degenerate  at  around  2  years  of  age.
hen  this  process  continues  they  may  grow  or  become
alignant  and  are  functional  as  both.  Hyperplasia  (70%)
nd  thymomas  (15%)  with  myasthenia  gravis  may  occur,  as
he  T  lymphocytes  are  intolerant  to  anti-acetylcholine  anti-
odies.6 The  thymus  may  be  a  location  for  lung,  breast
r  thyroid  cancer  metastasis.  Thymoma  is  a  low  frequency
umour  of  uncertain  patterns  of  behaviour.  It  corresponds
o  26--50%  of  mediastinal  tumours  and  to  82%  of  thymus
umours4,6,7;  diagnosis  is  generally  incidental  and  occurs
hrough  chest  X-ray  and  a  CAT  scan  to  determine  the  location
nd  extension  of  the  tumour.5,6 With  regards  to  thymoma
lassiﬁcation,  although  no  standard  classiﬁcation  exists,
he  one  proposed  by  Masaoka  et  al.3 is  the  most  com-
only  used.  This  classiﬁcation  is  divided  into  4  categories
n  accordance  with  the  stage  of  tumour  inﬁltration  into:  I,
apsule  intact;  II,  invasion  of  the  capsule;  III,  macroscopic
nvasion  into  neighbouring  organs;  IVa  and  IVb,  pleural  or
ericardial  dissemination  and  lymphogenous  or  haematoge-
ous  metastasis  to  distant  sites  respectively.  The  WHO
lassiﬁcation  is:  epitelial  A,  mixed  AB,  lymph  node  B1,
pindle-shaped  B2  and  thymic  carcinoma.4,6,7 Thymic  car-
inoma  is  the  neoplasm  with  the  highest  malignancy  of  the
hymus.  Symptoms  tend  to  present  earlier  and  are  aggres-
ive  with  pain,  weight  loss,  superior  vena  cava  syndrome,
yspnoea  caused  by  pericardial  effusion  and  compression
f  the  airway.  It  is  rare  and  presentation  is  atypical  of
ts  cells  which  are  not  similar  in  appearance  to  the  orig-
nal  thymus  ones.  It  represents  around  5%  of  mediastinal
umours  in  adults  and  accounts  for  approximately  1--2%
f  mediastinal  tumours  in  children.1,2,4,7--9 The  treatment
f  choice  for  thymus  tumour  is  surgical  resection.4--6,9,10
hich  may  consist  of  sternotomy,  upper  cervical  sternotomy,
horacotomy,  video-assisted  thoracoscopy,  mediastinoscopy
nd  ideally  total  surgical  resection.  If  the  latter  is  not
erformed  treatment  is  complemented  with  radiotherapy
nd/or  chemotherapy  depending  on  the  tumour  type,  inva-
ion  and  extension.4,6--10 Surgical  complications  may  be
neumonia,  haemothorax,  pneumothorax,  sternal  dehis-
ence,  mediastinitis,  osteomyelitis10 and  less  frequently
3 A.L.  Nolasco-de  la  Rosa  et  al.
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Figure  1  CAT  scan.  A  central  mass  is  observed  which  affects
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performed,  and  the  normal  thyroid  glands  and  multiple  ade-
nomegalies  at  levels  IV,  V  and  VI  were  located.  The  tumour
was  resectioned  and  ganglionic  emptying  was  performed26  
hylothorax,  diaphragmatic  paralysis,  dysphonia  and  myas-
henic  crisis.
linical case
his  is  the  case  of  a  4-year-old  female  child,  the  mother’s
econd  child,  and  who  had  a  normal  pregnancy,  and  normal
elivery  at  39  weeks.  APGAR  was  8/9.  The  child  weighed
.100  g  at  birth,  development  was  normal  and  she  was
ent  for  consultation  due  to  an  increase  in  neck  volume  at
he  age  of  2  months.  There  was  no  dysphnoea,  dysphagia,
yanosis,  paleness,  fever,  cough,  weight  loss  or  neuromus-
ular  changes.  On  examination  the  patient  was  found  to  be
utrophic,  with  a  heart  beat  of  100/min,  breathing  rate  of
8/min,  a  temperature  of  36.2 ◦C,  saturation  at  a  mean  of
7%,  weight  of  19  kg,  with  no  dyspnoea  or  dysphonia,  with
orrect  skin  colouring,  well  hydrated,  with  no  hyperaemia
f  the  larynx.  Her  neck  had  an  increased  volume  of  approx-
mately  1.5--2  cm  in  supra  sternal  cavity  area  I,  which  was
oft,  pain  free,  not  moveable,  and  had  a  smooth  surface,
f  renitent  consistency,  with  no  changes  of  skin  tone,  no
ovement  on  swallowing.  Her  thyroid  glands  were  without
alpable  mass,  were  mobile  and  pain  free.  Adenomegalies
ere  soft,  approximately  5--7  mm  in  bilateral  III--IV  jugular
ymph  node  chain,  were  pain  free,  smooth  in  surface,
obile,  and  not  attached  to  any  deep  tissues.  Her  chest  had
o  deformations,  air  entered  and  exited  successfully,  and
here  were  no  crackling  or  wheezing,  no  heart  murmurs,
one  and  intensity  were  good  with  no  additional  pufﬁng.
he  abdomen  was  soft,  easily  depressed,  was  pain  free  and
ithout  visceromegalias.  Peristalsis  was  normal  and  active.
imbs  were  intact,  with  immediate  capillary  reﬁll,  and  no
yanosis.  Laboratory  tests  reported:  leukocytes  of  5600/l,
aemoglobin  of  14.6  g/dl,  platelets  of  324,000/l,  47.6%  of
otal  reactive  lymphocytes,  31%  total  neutrophils,  alkaline
hosphatise  raised  to  250  UI/l  (40--150),  normal  transami-
ase,  amylase  of  92  U/l,  lipase  19/l,  cholesterol  169  mg/dl,
riglycerides  68  mg/dl,  uric  acid  3.5  mg/dl,  normal  coagu-
ation  ranges,  total  bilirubin  0.1  mg/dl,  albumin  of  3.1  g/dl,
lucose  96  mg/dl,  ureic  nitrogen  of  10  mg/dl,  creatinine  of
.46  mg/dl,  calcium  of  9.1  mg/dl,  sodium  of  140  mmol/l,
otassium  of  4  mmol/l,  chlorine  of  110  mmol/l,  phosphate
f  4.3  mg/dl,  magnesium  of  2.4  mg/dl,  a  normal  general
rine  test,  stimulating  folic  hormone  of  13.5  ml  U/ml,
uteinizing  hormone  of  0.36  ml  U/ml,  prolactin  of  25  ng/ml,
arcinoembryonic  antigen  of  2.1  ng/ml  all  tested  normal.
ormal  thyroid  proﬁle  with  T3T  15.7  ng/dl,  TSH  2.61  U/ml,
4L  0.97/ml,  eosinophils  in  nasal  mucosa  tested  negative,
mmunoglobulin  G  887  mg/dl  (681--1648),  immunoglobu-
in  A  117  mg/dl  (84--484),  immunoglobulin  M  285  mg/dl
48--312),  immunoglobulin  E  18.34  mg/dl  (under  60),  neg-
tive  co-parasitoscopic  tests.  Negative  nasal  and  laryngeal
xudation  were  found.  Neck  ultrasound  reported  a  simple
eft  thyroid  cyst.  Neck  tomography  showed  a  rounded,
eterogenous  tumour  of  1  cm  in  supra  sternal  cavity,  and  an
rregular,  heterogenous  mass  in  the  superior  mediastinum,
ith  partial  compression  of  mediastinal  structures,  and
tage  II,  III  and  VII  stage  cervical  adenomegaly,  approxi-
ately  0.8  cm  in  size  with  no  pleural  effusion  or  pleural
r  parenchymal  involvement  (Figs.  1  and  2).  Surgery  was
erformed  with  general  anaesthesia,  in  the  Rosier  position.
F
i
ahe anterosuperior  mediastinum  and  surrounds  the  aorta  and
ena cava,  minimum  compression  of  airway.
 transverse  cervical  incision  was  made.  The  rounded
hinly  encapsulated  tumour  was  located  at  the  pre-thyroid
upra  sterna  region.  It  was  yellow  in  colour,  and  extended
owards  the  anterior  mediastinum  surrounding  the  aorta
nd  cava  superior.  Upper  median  sternotomy  was  thereforeigure  2  CAT  scan,  lateral  slice.  A  large  heterogeneous  mass
s noted  extending  from  the  neck,  superior  and  anterior  medi-
stinum,  with  minimum  compression  of  airway.
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Figure  3  Histological  image  with  HE  staining  where  the  loss  of
normal structure  is  noted,  with  no  medullary  residues  and  with
a network  of  large  neoplastic  cells,  with  large  vesicular  nuclei,
F
a
g
v
m
D
T
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m
gand prominent  nucleoli  in  the  network  of  vessels  and  septa,  and
with scattered  immature  lymphocytes  around  the  blood  vessels.
at  mediastinal  levels  IV,  V  and  VI  and  cervical  levels  II  and
III  approximately.  A  19  Fr  mediastinal  probe  was  inserted
and  we  proceeded  with  Penrose  type  drainage  in  the  neck.
Vicryl  suture  closure  was  of  the  sternotomy  was  carried  out.
The  control  CAT  scan  showed  correct  lung  expansion,
with  no  effusion.  The  Penrose  drainage  was  removed  on  day
two.  On  day  three  the  mediastinal  probe  was  removed  and
the  patient  was  discharged  from  the  hospital.  Histopatho-
logic  ﬁndings  showed:  inclusion  cyst  with  queratin,  neck  and
mediastinal  lymph  nodes  with  no  neoplastic  cells  but  with
lymphoid  hyperplasia.  Lymphocyte  thymoma  was  B1  on  the
WHO  or  Masaoka  I  classiﬁcation  scale  (Figs.  3  and  4);  ﬁnd-
ings  were  sent  for  assessment  by  the  paediatric  oncology
department  which  considered  that  no  coadjuvant  manage-
ment  was  required.  The  patient  was  asymptomatic  4  months
after  surgery,  with  no  signs  of  miastenia  gravis.  The  con-
trol  scan  showed  the  neck  with  no  adenomegaly,  the  thyroid
Figure  4  Mixed  celluarity  is  noted  with  rounded  poygonal
cells with  prominent  vesicular  nuceoli,  lymph  cells  of  imma-
ture appearance  mixed  together  which  adopt  a  diffuse  pattern.
No invasion  of  the  capsular.
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tigure  5  Control  CAT  scan,  with  no  evidence  of  a  tumour,
orta with  no  obstruction.
land  as  normal,  central  mediastinum  without  mass,  large
essels  with  no  lesions,  pulmonary  parenchymas  with  no
asses,  and  no  pleural  effusion  (Fig.  5).
iscussion
hymomas  are  rare  even  in  adults.  In  children  the  medi-
al  approach  takes  into  account  the  anatomic  site  of  the
ediastinum  and  the  patient’s  age,  since  those  of  neuro-
enic  origin  are  more  frequently  found  in  children  under
 and  those  of  lymphatic  origin  in  school  age  children
nd  teenagers2--4;  they  may  be  associated  with  miaste-
ia  gravis  or  not,  although  it  is  known  that  approximately
5--25%  of  patients  with  miastenia  have  thymoma  and  that
f  patients  with  malignant  or  benign  thymic  growth,  35--50%
ill  develop  miastenia  gravis.6 Miastenia  gravis  is  a  disease
f  the  motor  nerve,  characterised  by  fatigue  and  muscu-
ar  weakness,  its  base  is  auto  immune  with  the  presence
f  anti-bodies  against  the  acetylcholine  receptors.  It  was
rst  described  in  1672  by  Thomas  Willis,  but  classiﬁed  by
sserman  into  the  childhood  stage,  neonatal,  congenital,
oung  and  young  adult  under  40  stages  and  sub-classiﬁed
nto:  stage  I,  ocular  uni-  or  bilateral;  stage  IIa  generalised;
tage  IIb,  generalised  and  bulbous;  stage  III  severe  respira-
ory;  and  stage  IV  chronic  respiratory,  with  stages  IIa,  IIb
nd  III  being  those  that  beneﬁt  from  thymectomy.2,4,6 It  is
 times  more  common  in  women.  Apart  from  miastenia,  in
ddition  to  thymomas  and  thymic  carcinomas  (Masaoka  IV,
HO  C)  pure  anaemia  of  red  blood  cells  may  present,  as  may
ypogammaglobulinaemia,  rheumatoid  arthritis,  systemic
rythematosus  lupus,  pemphigus,  polymyositis,  Hashimoto
5hyroiditis,  and  nephrotic  syndrome. In  our  study  we  pre-
ented  the  case  of  a  4  year  old  patient,  classiﬁed  as  thymoma
ype  B1  Masaoka  I,  with  no  symptoms  associated  with  the
umour  and  only  raised  reactive  lymphocytes.  Diagnosis  of
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he  mediastinal  tumour  was  made  from  a  scan  ﬁnding2,4,5
nd  conﬁrmed  by  the  histopathologic  report.  The  miaste-
ia  up  until  that  time  has  not  developed,  but  considering
he  past  history  and  the  fact  this  was  a  female  patient,  it
ould  be  expected  to  present  in  the  future.1,3,4,6 The  thy-
oma  must  be  considered  as  a  malignant  tumour.1,2,7--10 and
isuse  of  the  term  benign  thymoma,  used  for  Masaoka  type
 tumours,  is  now  recommended.
Thanks  to  the  advance  of  surgical  techniques,  approaches
nd  chemotherapy  treatments2--4,6--10 for  cancer  manage-
ent  in  children  there  are  more  favourable  results  regarding
urvival.  The  treatment  of  choice  will  depend  on  the
istopathological  report  and  the  spread  of  the  tumour.
urgery  is  initially  chosen,  except  in  the  case  of  germinal
nd  lymphatic  tumours7,8 where  radiotherapy  is  the  treat-
ent  of  choice,  once  diagnosis  has  been  made.  Ideal  surgery
s  R0  (total)  resection.  In  the  case  of  R1  and  R2  surgery
ust  be  accompanied  by  radio  and/or  chemotherapy.1,2,4,5
hemotherapy  for  this  type  of  tumour  is  based  on  cisplatin,
yclophosphamide,  steroids  and  adriamycin.  A  85--100%  sur-
ival  rate  of  5  years  has  been  reported  in  Masaoka  I tumours,
0--90%  in  Masaoka  type  II  tumours,  59--75%  in  Masaoka
ype  IIIa  tumours  and  a  40%  and  10%  rate  in  Masaoka  IVa
nd  IVb  type  tumours  respectively.3,4,7,8,10 When  the  tumour
s  mediastinal,  and  particularly  anterior  mediastinal,  it  is
ssential  to  carry  out  a  preoperative  anaesthetic  assess-
ent  since  the  tumour  itself  may  be  compressing  the  airway
nd  vascular  structures,  which  would  pose  a  challenge
or  intubation.  Furthermore,  even  if  the  patient  does  not
resent  with  pre-surgical  compression,  once  the  patient  is
elaxed,  severe  compression  may  occur  and  with  it  intuba-
ion  complications.1,2
onclusions
lthough  thymic  tumours  are  rare  in  children,  when  a lower
ervical  tumour  or  anterior  mediastinal  tumour  presents,
he  possibility  of  a  mediastinal  tumour  should  be  considered
ven  in  the  absence  of  associated  symptoms,  as  this  may
void  delay  in  diagnosis  and  thereby  its  treatment.  When  the
umour  presents  without  symptoms  this  may  be  associated
1A.L.  Nolasco-de  la  Rosa  et  al.
ith  a  benign  tumour.  However,  there  are  no  studies  which
pecify  this  and  it  is  known  that,  as  with  any  tumour,  prog-
osis  will  depend  on  the  stage  at  which  the  tumour  is  found,
he  degree  of  surgical  resection,  the  degree  of  inﬁltration
nd  lymph  node  metastasis,  haematological  changes  and  the
resence  or  absence  of  miastenia  gravis.
onﬂict of interests
he  authors  have  no  conﬂict  of  interests  to  declare.
eferences
1. Fonseca AL, Ozgediz DE, Christison-Lagay ER, Detter-
beck FC, Caty MG. Pediatric thymomas: report of two
cases and comprehensive review of the literature. Pedi-
atr Surg Int. 2014;30:275--86, http://dx.doi.org/10.1007/
s00383-013-3438-x.
2. Calderón EC, Kieffer ELF, Ruano AJ, Hernández AD, Ramírez
RA. Diagnóstico y tratamiento de masas mediastinales en nin˜os.
Revisión de la literatura. Acta Pediatr Mex. 2005;26:79--89.
3. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study
of thymomas with special reference to their clinical stages.
Cancer. 1981;48:2485--92.
4. Santillán Doherty P. Tumores mediastinales. Rev Invest Clin.
2006;58:245--53.
5. Montella L, Masci AM, Merkabaovi G, Perna F, Vitiello L, Racioppi
L, et al. B-cell lymphopenia and hypogammaglobulinemia in
thymoma patients. Ann Hematol. 2003;82:343--7.
6. Choid Decroos E, Hobson-Webb LD, Juel VC, Massey JM, Sanders
DB. Do acetylcholine receptor and striated muscle antibodies
predict the presence of thymoma in patients with myasthenia
gravis? Muscle Nerve. 2014;49:30--4.
7. Yaris N, Nas Y, Cobanoglu U, Yavuz MN. Thymic carcinoma in
children. Pediatr Blood Cancer. 2006;47:224--7.
8. Allan BJ, Thorson CM, Davis JS, van Haren RM, Parikh PP, Perez
EA, et al. An analysis of 73 cases of pediatric malignant tumors
of the thymus. J Surg Res. 2013;184:397--403.
9. Santillán Doherty P, Martin del Campo LA. Neoplasias epiteliales
del timo. Ciruj Gral. 2010;32 (Suppl. 1):75--7.
0. Molinaro F, Garzi A, Cerchia E, Angotti R, di Maggio G, Valla SJ,
et al. Thoracoscopic thymectomy in children: our preliminary
experience. J Laparoendosc Adv Surg Tech A. 2013;23:556--9.
